Home / Products / Genome-edited Cells / CD19 Overexpression NALM-6 Stable Cell Line
CD19 Overexpression NALM-6 Stable Cell Line
Datasheet Protocol

CD19 Overexpression NALM-6 Stable Cell Line

Cat. No. ARG0595
Product Type:

Genome-edited Cells

Tissue Source:

Blood (peripheral blood)

In stock
Request a Quote
Request Quote Ask a Question

Short Description 🔒

The CD19 Overexpression NALM-6 Stable Cell Line is an overexpression cell line. The gene/protein CD19 was overexpressed in the NALM-6 cell line by lentiviral transduction or other editing tools. After selection and expansion, the modified cells become an overexpression stable cell line.

Recommended Products

C2CD2L Knockout A2780 Polyclonal Cells C2CD2L Knockout A2780 Polyclonal Cells Cat. No. ARG28956 MFGE8 Knockout NCI-H1703 Polyclonal Cells MFGE8 Knockout NCI-H1703 Polyclonal Cells Cat. No. ARG12593 CD34 Knockout 143B Polyclonal Cells CD34 Knockout 143B Polyclonal Cells Cat. No. ARG43521 KCTD12 Knockout HAP1 Polyclonal Cells KCTD12 Knockout HAP1 Polyclonal Cells Cat. No. ARG27663 FLG2 Knockout Raji Polyclonal Cells FLG2 Knockout Raji Polyclonal Cells Cat. No. ARG1390 C127 C127 Cat. No. ARC0084
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Genome-edited Cells
Tissue Source:
Blood (peripheral blood)
Disease:
Acute lymphoblastic leukemia (ALL)
Age:
19 years
Sex of Donor:
Male
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

Host Cell:
NALM-6
Gene Name:
CD19

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

MARVELD2 Knockout HT29 Polyclonal Cells

MARVELD2 Knockout HT29 Polyclonal Cells

Cat. No. ARG14286
 ARID4A Knockout HEK293T Polyclonal Cells

ARID4A Knockout HEK293T Polyclonal Cells

Cat. No. ARG25740
 HP1BP3 Knockout SK-HEP-1 Polyclonal Cells

HP1BP3 Knockout SK-HEP-1 Polyclonal Cells

Cat. No. ARG32608
 LCP1 Knockout HCT116 Polyclonal Cells

LCP1 Knockout HCT116 Polyclonal Cells

Cat. No. ARG7113
 CSK Knockout 786-O Polyclonal Cells

CSK Knockout 786-O Polyclonal Cells

Cat. No. ARG5521
 MARK3 Knockout Raji Polyclonal Cells

MARK3 Knockout Raji Polyclonal Cells

Cat. No. ARG1947